Wall street is trading with a correction after its best quarter in decades. The Dow Jones managed to overcome the coronavirus crisis with a rebound of 17.8% in the second quarter of the year. This was followed by the S&P 500 and its 20% gain and the Nasdaq, with a rise of 30.6% in the period driven by its technology companies.
On the business front, FedEx it shoots up 9% after publishing quarterly results that have beaten market expectations.
In political matters, Trump is again in the news. The president of the USA has secured the first stocks of the Redemsivir, one of the first two effective drugs against the virus, at least for the next three months.
"Trump has reached an incredible agreement to ensure that Americans have access to the first authorized therapeutic treatment for Covid-19," the US Secretary of Health has announced.
The agreement gives the US exclusivity on the drug's stocks for the next three months. The first 140,000 doses of Gilead have already been purchased by Trump, who has ordered another 500,000 more, thus ensuring all production in July and 90% in August and September.
In economic matters, the United States again shows certain signs of weakness and creates less private employment than expected by economists.
Across the Atlantic, the Ibex and the rest of Europe give way despite the improvement in the recently published macro data. Finally, in Asia the stock markets have closed with a mixed sign.